Bio-defense(less)?

Biorisk is real, but we’re having the wrong debates. Could the AI-first bio tools we use to design life-saving vaccines also be used to evade the screening protocols of DNA synthesis companies? How easy is it for non-state actors to use these tools? How worried should we be? We dive into all of this and more in this article on Air Street Press. Read more at: https://press.airstreet.com/p/bio-defenseless

Om Podcasten

As an AI-native investor, we believe it’s important to be a hands-on contributor to the community. Since our earliest days, we’ve been building in public - whether that’s sharing our perspectives on the direction of the field, emerging best practice for building AI-first companies, organizing meet-ups, and campaigning for policy change. Air Street Press brings together all of our content under one umbrella. Subscribe to listen to our analysis, portfolio news, Guide to AI monthly newsletter, annual State of AI Report, and our policy work.